Recently added item(s)

Buy Quality Bay 38-7271 Crystals Online

$400.00$2,380.00

Buy Quality Bay 38-7271 Crystals Online It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury. It is a full agonist with around the same potency as CP 55,940 in animal studies,is high quality Research Chemicals. You can buy Bay 38-7271 online at wholesale price from trust supplier Alfamedchemical.com

SKU: N/A Category:
Clear
Compare

Description

Buy Quality Bay 38-7271 Crystals Online

 

Description

Buy Quality Bay 38-7271 Crystals Online is high quality Research Chemicals. You can buy BAY 38-7271 online at wholesale price from trust supplier Alfamedchemical.com

BAY 38-7271 Originally synthesized by chemist Wayne E. Kenney, BAY 38-7271 (KN 38-7271) is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.

It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury. It is a full agonist with around the same potency as CP 55,940 in animal studies, and has fairly high affinity for both CB1 and CB2 receptors, with Ki values of 2.91nM at CB1 and 4.24nM at CB2. It has been licensed to KeyNeurotek Pharmaceuticals for clinical development, and is currently in Phase II trials.But its development appears has stopped.

CAS: 212188-60-8

Formula: C20H21F3O5S

Purity: 99,7% min

Molecular weight: 311.461

Appearance: Need to clarify

BAY 38-7271 Originally synthesized by chemist Wayne E. Kenney, BAY 38-7271 (KN 38-7271) is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.

It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury. It is a full agonist with around the same potency as CP 55,940 in animal studies, and has fairly high affinity for both CB1 and CB2 receptors, with Ki values of 2.91nM at CB1 and 4.24nM at CB2. It has been licensed to KeyNeurotek Pharmaceuticals for clinical development, and is currently in Phase II trials.But its development appears has stopped.

CAS: 212188-60-8

Formula: C20H21F3O5S

Purity: 99,7% min

Molecular weight: 311.461

Appearance: Need to clarify

BAY 38-7271 Originally synthesized by chemist Wayne E. Kenney, BAY 38-7271 (KN 38-7271) is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.

X